Bedaquiline Fumarate molecular structure

Bedaquiline Fumarate

Also known as: Sirturo, Bedaquin, BDQ

CAS Number: 845533-86-0

Antitubercular (Diarylquinoline ATP Synthase Inhibitor)

Pharmacopeia Standards

WHO

Mechanism of Action

Bedaquiline binds the oligomeric c-ring subunit of mycobacterial ATP synthase and blocks proton translocation through the F0 domain. Loss of proton motive force coupling collapses ATP generation in both replicating and non-replicating bacilli. This novel target gives it no cross-resistance with rifamycins, isoniazid or fluoroquinolones, which is why it anchors modern all-oral MDR-TB regimens.

Technical Specifications

Generic / INN NameBedaquiline Fumarate
CAS Registry Number845533-86-0
Molecular FormulaC32H31BrN2O2 · C4H4O4
Molecular Weight671.58 g/mol (free base 555.50 g/mol) g/mol
Typical PurityNot less than 98.0% (in-house HPLC, on anhydrous basis)
Storage ConditionsStore below 25 degrees C in tightly closed, light-resistant containers in a dry place; protect from light and moisture
Shelf Life36 months from date of manufacture when stored as directed
CategoryAnti-Tubercular Agents

Specifications are indicative and intended for sourcing reference only. Always confirm against the supplier's Certificate of Analysis and the applicable pharmacopeial monograph before issuing a purchase specification.

Typical Applications

Bulk API for 20 mg and 100 mg bedaquiline tablets used in all-oral drug-resistant TB regimens including BPaL and BPaLM. Also supplied for co-formulation development and paediatric dispersible tablet programmes.

Manufacturers (0+)

View all →
No manufacturers listed yet. Register your company to appear here.